Page last updated: 2024-08-21

calcium citrate and Spasm

calcium citrate has been researched along with Spasm in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bajnok, L; Bilezikian, JP; Brandi, ML; Clarke, BL; Fraser, WD; Garceau, R; Lagast, H; Lakatos, P; Mannstadt, M; Mosekilde, L; Ranganath, L; Shoback, D; Vokes, T	1

Trials

1 trial(s) available for calcium citrate and Spasm

Article	Year
Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study. The lancet. Diabetes & endocrinology, 2013, Volume: 1, Issue:4 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium Citrate; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Hypoparathyroidism; Injections, Subcutaneous; Male; Middle Aged; Parathyroid Hormone; Recombinant Proteins; Spasm; Treatment Outcome; Vitamin D; Young Adult	2013

Article

Year

Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study.

The lancet. Diabetes & endocrinology, 2013, Volume: 1, Issue:4

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Calcium Citrate; Double-Blind Method; Drug Therapy, Combination; Female; Headache; Humans; Hypoparathyroidism; Injections, Subcutaneous; Male; Middle Aged; Parathyroid Hormone; Recombinant Proteins; Spasm; Treatment Outcome; Vitamin D; Young Adult

2013